Latest News

Paychex's GAAP profits were worse than its non-GAAP profits, and FCF was even worse than GAAP!

Today, Sept. 23, 2026, bond yields and geopolitical tensions weigh on U.S. indexes, while cybersecurity stocks rally.

Although Wood's company bought this stock, it may have had other motivations.

Oswaldo Tadeu Fernandes raised his direct stake by 30%, signaling confidence in the Brazilian financial giant. The purchase occurred at $17.98 per share on a weighted-average basis.

Gold rebounded after briefly dipping on the Fed's rate hike, as central bank buying persists. Newmont, Wheaton Precious Metals, and iShares Silver Trust offer distinct ways to invest in the trend.

Invesco's QQQ Trust is still one of the easiest ways to beat the market.

Canopy Growth's stock has continued to fall, prompting the company to proactively seek to retain access to capital markets.

Stanley Druckenmiller recently initiated a large position in Tesla, but his investment thesis might not have anything to do with artificial intelligence.

Milton Hershey School Trust maintains substantial voting power through 54.6 million convertible Class B shares despite the modest equity reduction.

Both stocks could merit being long-term investments.

This lesser-known nuance could prevent a long-term benefit cut.

Resale inventory hits decade highs, pressuring margins as KB Home navigates weakening demand.

Thor Industries stock trades near the low end of its range amid an RV industry slump, but steady dividends, institutional buying, and analyst price targets suggest upside potential ahead.

The GE Vernova stock price is still a good distance from its 52-week high, but it's still a company worth considering as an investable opportunity.

AGF Management (TSE:AGF.B) reported third-quarter 2026 adjusted diluted earnings per share of CAD 0.49, adjusted EBITDA of CAD 49 million and free cash flow of CAD 39 million, as growth in assets under management and retail sales momentum supported results. Chief Executive Officer Judy Goldring sai

Regeneron Pharmaceuticals (NASDAQ:REGN) executives highlighted continued growth across key marketed products, a broad late-stage pipeline and an ongoing focus on science-driven business development during a discussion with Bernstein analyst Jeffrey Walch. Chris Fenimore, Regeneron’s executive vice

Paychex (NASDAQ:PAYX) reported a solid start to fiscal 2027, posting first-quarter revenue growth of 6% and double-digit gains in operating income and earnings per share as growth in its professional employer organization, or PEO, and insurance businesses outpaced expectations. Total first-quarter

Cintas (NASDAQ:CTAS) reported fiscal 2027 first-quarter revenue of $3.01 billion, up 10.9% from a year earlier and marking the first time the company exceeded $3 billion in quarterly revenue. Organic revenue growth, which excludes acquisitions, foreign currency movements and workday differences, was

There are not many ETFs that can match this ETF on performance.

Biotech stocks widely slumped Wednesday, with Rapport, Climb Bio and Cullinan among some of the hardest-hit names.

Up 76% in 3 months, can Palantir stock keep powering higher?

We may be seeing the beginning of Meta's next major growth engine.

Cerebras is posting $510M in revenue with 76% growth and profitability, while Rigetti burns cash despite backing from Amazon and Microsoft.

Aritzia’s stock is down nearly 30%, but the business just posted one of its best quarters ever.

Outdoor surfaces naturally collect dirt, dust, pollen, rain residue, leaves, mud, and other contaminants. As this buildup increases, driveways, patios, wal